Business
Bionano Genomics Announces ESHG Lineup Featuring 11 Customer Presentations of OGM Data Spanning Three Major Clinical Research Areas of Application from 10 Institutions and Six Countries
SAN DIEGO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"SAN DIEGO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference lineup featuring 11 customer presentations of optical genome mapping (OGM) data spanning three major clinical areas of application from 10 institutions and six countries. The clinical application areas represented below cover hematological malignancies, inherited genetic disorders and solid tumor analysis. The presentations are expected to cover the clinical utility of OGM across these application areas, along with the unique capabilities of Bionano’s Saphyr® system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques. The ESHG conference is being held virtually starting this Saturday from August 28 - 31, 2021. More than 3,400 participants are registered for this year’s ESHG meeting, which provides a platform for the dissemination of the most exciting advancements in the field of human genetics. The upcoming customer presentations featuring OGM data are listed below along with the associated clinical areas of application: OGM Application AreaPresenterAffiliationPresentation/Poster TitleHematological MalignanciesDr. Anna PuiggrosHospital del Mar, Barcelona, SpainAnalysis of genomic complexity in patients with chronic lymphocytic leukemia (CLL) using optical genome mappingDr. Jonathan L. LühmannHannover Medical School, Hannover, GermanyThe clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemiaInherited Genetic DisordersDr. Caroline Schluth-BolardUniversite Hospital de Lyon, FranceWhat is the best solution to manage failures of chromosomal structural variations detection by short-read strategy?Dr. Kornelia NevelingRadboud University Medical Centre, NetherlandsLong-read technologies identify a hidden inverted duplication in a family with choroideremiaDr. Valérie RaceUniv. Hosp. of Leuven, Leuven, BelgiumBionano optical genome mapping and southern blot analysis for FSHD detectionDr. Romain NicolleHospital Necker-Enfants Malades, Paris, France16p13.11p11.2 triplication syndrome: a new recognizable genomic disorder characterized by Bionano optical genome mapping and WGSDr. Jenny SchillerMVZ Martinsried, Martinsried, GermanyCharacterization of breakpoi...